Two Sigma Advisers’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48M | Buy |
1,275,914
+433,314
| +51% | +$503K | ﹤0.01% | 1259 |
|
|
2025
Q1 | $1.34M | Sell |
842,600
-47,100
| -5% | -$74.9K | ﹤0.01% | 1331 |
|
|
2024
Q4 | $2.7M | Sell |
889,700
-259,700
| -23% | -$787K | 0.01% | 989 |
|
|
2024
Q3 | $4.23M | Buy |
1,149,400
+352,500
| +44% | +$1.3M | 0.01% | 767 |
|
|
2024
Q2 | $3.26M | Buy |
796,900
+695,900
| +689% | +$2.85M | 0.01% | 950 |
|
|
2024
Q1 | $1.59M | Buy |
+101,000
| New | +$1.59M | ﹤0.01% | 1344 |
|
|
2022
Q4 | – | Sell |
-22,600
| Closed | -$490K | – | 2724 |
|
|
2022
Q3 | $490K | Sell |
22,600
-32,700
| -59% | -$709K | ﹤0.01% | 1850 |
|
|
2022
Q2 | $1.55M | Sell |
55,300
-13,000
| -19% | -$365K | ﹤0.01% | 1350 |
|
|
2022
Q1 | $3.15M | Buy |
68,300
+1,500
| +2% | +$69.2K | 0.01% | 1017 |
|
|
2021
Q4 | $5.62M | Sell |
66,800
-69,300
| -51% | -$5.83M | 0.01% | 714 |
|
|
2021
Q3 | $9.07M | Buy |
136,100
+81,600
| +150% | +$5.44M | 0.02% | 550 |
|
|
2021
Q2 | $2.9M | Buy |
54,500
+17,500
| +47% | +$931K | 0.01% | 1120 |
|
|
2021
Q1 | $1.61M | Buy |
37,000
+23,900
| +182% | +$1.04M | ﹤0.01% | 1383 |
|
|
2020
Q4 | $680K | Buy |
+13,100
| New | +$680K | ﹤0.01% | 1744 |
|